In 2010 Botox® was licensed in the UK by the by the Medicines and Healthcare products Regulatory Agency for the treatment of chronic migraine. In June 2012 the National Institute of Clinical Excellence recommended “botulinum toxin type A as a possible treatment for preventing headaches in some adults with chronic migraine”
Botulism was first described in 1817. The bacterium responsible, Clostridium botulinum, produces a number of toxins that paralyse some muscles. A highly dilute preparation of one of these was introduced in clinical practice in the 1970s and 1980s to treat squint and blepharospasm. Since then it has found uses in other areas of medicine including dystonia (including writer’s cramp), post-stroke spasticity, and hyperhidrosis.
In the mid-1990s a number of people reported improvement in headaches. Clinical trials have subsequently shown that Botox can help with chronic migraine
The simple answer is that we don’t know fully.
The treatment consists of approximately 34 injections of Botox around the head and shoulder muscles. The needle is very fine indeed and the procedure is usually tolerated very well.
These will be discussed in detail at your consultation but greatest risk is that the eyebrows will be weakened and may appear to droop. Rarely there is also the risk of making the pain flare up for a few days afterwards. Very rarely people have had double vision and flu like symptoms; these are temporary.
95% OF PEOPLE WOULD RECOMMEND THE PAIN TEAM
The Pain Team whilst unable to do face to face consultations are able to conduct telephone consultations while the lockdown is in place with advice on medication issues for acute and chronic pain or the way forward when we are running a normal service.
Please contact email@example.com to discuss this service. Please put a contact telephone number on you email. Your location is also helpful.